Revel M - Search Results

1

Enhancement of interleukin 6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibody.

Novick D, Shulman LM, Chen L, Revel M. Novick D, et al. Among authors: revel m. Cytokine. 1992 Jan;4(1):6-11. doi: 10.1016/1043-4666(92)90029-q. Cytokine. 1992. PMID: 1617157

2

Abrogation of B16 melanoma metastases by long-term low-dose interleukin-6 therapy.

Katz A, Shulman LM, Porgador A, Revel M, Feldman M, Eisenbach L. Katz A, et al. Among authors: revel m. J Immunother Emphasis Tumor Immunol. 1993 Feb;13(2):98-109. doi: 10.1097/00002371-199302000-00004. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8318501

3

Combined therapy with IL-6 and inactivated tumor cells suppresses metastasis in mice bearing 3LL lung carcinomas.

Katz A, Shulman LM, Revel M, Feldman M, Eisenbach L. Katz A, et al. Among authors: revel m. Int J Cancer. 1993 Mar 12;53(5):812-8. doi: 10.1002/ijc.2910530518. Int J Cancer. 1993. PMID: 8449606

4

Terminal differentiation of myeloleukemic M1 cells induced by IL-6: role of endogenous interferon.

Gothelf Y, Raber J, Chen L, Schattner A, Chebath J, Revel M. Gothelf Y, et al. Among authors: revel m. Lymphokine Cytokine Res. 1991 Oct;10(5):369-75. Lymphokine Cytokine Res. 1991. PMID: 1768740

5

IL-6 receptors and sensitivity to growth inhibition by IL-6 in clones of human breast carcinoma cells.

Chen L, Shulman LM, Revel M. Chen L, et al. Among authors: revel m. J Biol Regul Homeost Agents. 1991 Oct-Dec;5(4):125-36. J Biol Regul Homeost Agents. 1991. PMID: 1803860

6

Interleukin-6 induces the (2'-5') oligoadenylate synthetase gene in M1 cells through an effect on the interferon-responsive enhancer.

Cohen B, Gothelf Y, Vaiman D, Chen L, Revel M, Chebath J. Cohen B, et al. Among authors: revel m. Cytokine. 1991 Mar;3(2):83-91. doi: 10.1016/1043-4666(91)90027-b. Cytokine. 1991. PMID: 1888886

7

Monoclonal antibodies to the soluble human IL-6 receptor: affinity purification, ELISA, and inhibition of ligand binding.

Novick D, Engelmann H, Revel M, Leitner O, Rubinstein M. Novick D, et al. Among authors: revel m. Hybridoma. 1991 Feb;10(1):137-46. doi: 10.1089/hyb.1991.10.137. Hybridoma. 1991. PMID: 2032732

8

Purification of soluble cytokine receptors from normal human urine by ligand-affinity and immunoaffinity chromatography.

Novick D, Engelmann H, Wallach D, Leitner O, Revel M, Rubinstein M. Novick D, et al. Among authors: revel m. J Chromatogr. 1990 Jun 27;510:331-7. doi: 10.1016/s0021-9673(01)93767-7. J Chromatogr. 1990. PMID: 2144854

9

Monoclonal antibodies for affinity purification of IL-6/IFN- beta 2 and for neutralization of HGF activity.

Novick D, Eshhar Z, Revel M, Mory Y. Novick D, et al. Among authors: revel m. Hybridoma. 1989 Oct;8(5):561-7. doi: 10.1089/hyb.1989.8.561. Hybridoma. 1989. PMID: 2680901

10

Interleukin-6 protects ductal breast carcinoma cells from MHC-unrestricted cell-mediated cytotoxicity.

Reiter Z, Chen L, Revel M, Rubinstein M. Reiter Z, et al. Among authors: revel m. Lymphokine Cytokine Res. 1992 Jun;11(3):175-81. Lymphokine Cytokine Res. 1992. PMID: 1327193

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

678 results

Search Page

Filters